SF 1627

Status in the House for the 90th Legislature (2017 - 2018)

Current bill text: As Introduced
Version List

Companion: HF1832
Companion Text
House Search

Revisor number: 17-3575

Long Description

Further Committee Actions

Fiscal Notes

Engrossments	Comparisons
Introduction		Posted on 02/28/2017	compared with HF1832 as Introduced

Description

Health plans required to indicate coverage level of anticancer medication.

House Actions	Senate Actions
03/01/2017
	Introduction and first reading pg. 925 Intro Referred to Commerce and Consumer Protection Finance and Policy
03/06/2017
	Author added Kent pg. 1081
03/09/2017
	Comm report: To pass pg. 1197 Second reading pg. 1244
04/27/2017
	Special Order pg. 3341 Third reading Passed pg. 3341 vote: 64-0
05/01/2017
Received from Senate pg. 4433 Senate file first reading, referred for comparison HF1832 pg. 4435
05/04/2017
Bills identical, SF substituted on General Register pg. 4450 Second reading pg. 4460
Final Actions
House rule 4.20, interim disposition of bills, returned to Commerce and Regulatory Reform pg. 7028	See First Special Session, SF2, Art. 5, Sec. 3